# AGGF1

## Overview
AGGF1, or angiogenic factor with G-patch and FHA domains 1, is a gene that encodes a multifunctional protein involved in angiogenesis and vascular development. The AGGF1 protein is characterized by its structural motifs, including a forkhead-associated (FHA) domain and a G-patch domain, which contribute to its role in nucleocytoplasmic transport and RNA binding, respectively (Chen2012Functional; Fan2009Novel). Functionally, AGGF1 is pivotal in promoting endothelial cell proliferation, migration, and capillary tube formation, processes essential for new blood vessel formation (Lu2016Angiogenic). It also plays a significant role in venous specification and differentiation, particularly during embryogenesis, by activating the AKT signaling pathway (Chen2012Functional). AGGF1's interactions with proteins such as p53 and the SWI/SNF complex link it to pathways crucial for cellular stability and chromatin remodeling (Si2021Angiogenic; Bohnsack2021Regulation). Clinically, AGGF1 is associated with conditions such as Klippel-Trenaunay syndrome and various cancers, where its expression and mutations can influence disease progression and prognosis (Si2021Angiogenic; Fan2009Novel).

## Structure
The AGGF1 protein, encoded by the human AGGF1 gene, is an angiogenic factor characterized by several structural motifs. It contains an N-terminal coiled-coil motif, an OCRE motif, a forkhead-associated (FHA) domain, and a C-terminal G-patch domain (Chen2012Functional; Fan2009Novel). The FHA domain is crucial for nucleocytoplasmic transport and angiogenesis, interacting with 14-3-3α/β proteins to facilitate the protein's cytoplasmic distribution (Zhang2021FHA). The G-patch domain is associated with RNA binding, contributing to the protein's functional properties (Fan2009Novel).

AGGF1 is primarily localized in the nucleus, where it interacts with chromatin-associated proteins and plays a role in the β-catenin-mediated signaling pathway (Zhang2021FHA). The protein's nuclear localization is mediated by a nuclear localization signal (NLS) within the amino acid region 260-288 (Zhang2021FHA). Although the protein lacks a typical nuclear export signal, the FHA domain's interaction with 14-3-3α/β proteins is essential for its export to the cytoplasm (Zhang2021FHA).

The AGGF1 protein is involved in angiogenesis and vein specification, with its overexpression leading to increased angiogenesis and venous differentiation (Chen2012Functional). However, detailed information on the primary, secondary, tertiary, or quaternary structures of AGGF1 is not provided in the available context.

## Function
The AGGF1 gene encodes an angiogenic factor that plays a significant role in promoting angiogenesis, the formation of new blood vessels, which is crucial for processes such as wound healing and response to ischemic conditions. AGGF1 is involved in endothelial cell proliferation, migration, and capillary tube formation, essential processes in angiogenesis (Lu2016Angiogenic). It activates autophagy, a cellular process for degrading and recycling cellular components, which is necessary for its angiogenic effects. This activation occurs through the AGGF1-JNK signaling pathway, leading to the formation of autophagosomes (Lu2016Angiogenic).

AGGF1 is also involved in the regulation of venous specification and differentiation, particularly during embryogenesis. It activates the AKT signaling pathway, which is crucial for establishing venous cell fate, similar to how VEGFA functions in arterial specification (Chen2012Functional). In endothelial cells, AGGF1 expression is regulated by the transcription factor GATA1, which enhances its expression by binding to the AGGF1 promoter. This regulation is vital for maintaining endothelial cell function and promoting angiogenesis (Fan2009Novel). AGGF1's activity is crucial for maintaining vascular homeostasis and proper blood vessel function.

## Clinical Significance
Mutations and altered expression of the AGGF1 gene are associated with several diseases and conditions. AGGF1 is implicated in Klippel-Trenaunay syndrome (KTS), a congenital vascular disorder characterized by capillary and venous malformations, varicose veins, and tissue hypertrophy. A specific single nucleotide polymorphism (SNP) in the AGGF1 promoter, -294C>T, disrupts GATA1 binding, leading to reduced AGGF1 transcription and is linked to KTS (Fan2009Novel). 

In cancer, AGGF1 functions as a tumor suppressor by modulating p53 post-transcriptional modifications and stability. Somatic mutations in AGGF1, particularly in its FHA domain, have been identified in various cancers, including malignant melanoma and endometrial cancer. These mutations can impair AGGF1's interaction with p53, promoting tumor growth (Si2021Angiogenic). 

AGGF1 overexpression is also linked to poor prognosis in hepatocellular carcinoma (HCC), where it correlates with higher tumor grades and increased angiogenesis, as indicated by higher microvessel density (Wang2015Overexpression). 

In cardiovascular diseases, AGGF1 is involved in therapeutic angiogenesis and has been shown to block neointimal formation and vascular smooth muscle cell proliferation, which are critical in conditions like coronary artery disease and myocardial infarction (Si2018Angiotensin).

## Interactions
AGGF1 interacts with several proteins and nucleic acids, playing a significant role in various cellular processes. It directly interacts with the p53 protein, enhancing its stability and expression by modulating post-transcriptional modifications. This interaction occurs through the FHA domain of AGGF1, which binds to p53, potentially acting as a chaperone to stabilize the protein. AGGF1 also affects the expression of MDM2, an E3-ubiquitin ligase that regulates p53 ubiquitination, by decreasing MDM2 levels, thereby reducing p53 ubiquitination and increasing its stability (Si2021Angiogenic).

AGGF1's FHA domain is crucial for its interaction with 14-3-3α/β proteins, which is essential for its nucleocytoplasmic transport and angiogenic function. This interaction is necessary for AGGF1's cytoplasmic localization, as demonstrated by experiments showing that AGGF1 without the FHA domain remains in the nucleus and is unable to promote angiogenesis (Zhang2021FHA).

AGGF1 also interacts with the SWI/SNF complex, which is involved in chromatin remodeling, to activate β-catenin target genes such as LEF1 and AXIN2. This interaction links AGGF1 to the Wnt/β-catenin signaling pathway, which is important for its role in angiogenesis (Bohnsack2021Regulation).


## References


[1. (Lu2016Angiogenic) Qiulun Lu, Yufeng Yao, Zhenkun Hu, Changqing Hu, Qixue Song, Jian Ye, Chengqi Xu, Annabel Z. Wang, Qiuyun Chen, and Qing Kenneth Wang. Angiogenic factor aggf1 activates autophagy with an essential role in therapeutic angiogenesis for heart disease. PLOS Biology, 14(8):e1002529, August 2016. URL: http://dx.doi.org/10.1371/journal.pbio.1002529, doi:10.1371/journal.pbio.1002529. This article has 73 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.pbio.1002529)

[2. (Zhang2021FHA) Cui-Fang Zhang, Han-Ming Wang, Andong Wu, Yang Li, and Xiao-Li Tian. Fha domain of aggf1 is essential for its nucleocytoplasmic transport and angiogenesis. Science China Life Sciences, 64(11):1884–1894, January 2021. URL: http://dx.doi.org/10.1007/s11427-020-1844-0, doi:10.1007/s11427-020-1844-0. This article has 5 citations.](https://doi.org/10.1007/s11427-020-1844-0)

[3. (Si2021Angiogenic) Wenxia Si, Bisheng Zhou, Wen Xie, Hui Li, Ke Li, Sisi Li, Wenbing Deng, Pengcheng Shi, Chao Yuan, Tie Ke, Xiang Ren, Xin Tu, Xiaomei Zeng, Britta Weigelt, Brian P. Rubin, Qiuyun Chen, Chengqi Xu, and Qing Kenneth Wang. Angiogenic factor aggf1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via mdm2. Cancer Letters, 497:28–40, January 2021. URL: http://dx.doi.org/10.1016/j.canlet.2020.10.014, doi:10.1016/j.canlet.2020.10.014. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2020.10.014)

[4. (Chen2012Functional) Di Chen, Lei Li, Xin Tu, Zhan Yin, and Qing Wang. Functional characterization of klippel–trenaunay syndrome gene aggf1 identifies a novel angiogenic signaling pathway for specification of vein differentiation and angiogenesis during embryogenesis. Human Molecular Genetics, 22(5):963–976, November 2012. URL: http://dx.doi.org/10.1093/hmg/dds501, doi:10.1093/hmg/dds501. This article has 64 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/dds501)

[5. (Si2018Angiotensin) Wenxia Si, Wen Xie, Wenbing Deng, Yi Xiao, Sadashiva S. Karnik, Chengqi Xu, Qiuyun Chen, and Qing Kenneth Wang. Angiotensin ii increases angiogenesis by nf‐κb–mediated transcriptional activation of angiogenic factor aggf1. The FASEB Journal, 32(9):5051–5062, April 2018. URL: http://dx.doi.org/10.1096/fj.201701543rr, doi:10.1096/fj.201701543rr. This article has 21 citations.](https://doi.org/10.1096/fj.201701543rr)

[6. (Bohnsack2021Regulation) Katherine E. Bohnsack, Ralf Ficner, Markus T. Bohnsack, and Stefanie Jonas. Regulation of deah-box rna helicases by g-patch proteins. Biological Chemistry, 402(5):561–579, January 2021. URL: http://dx.doi.org/10.1515/hsz-2020-0338, doi:10.1515/hsz-2020-0338. This article has 44 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/hsz-2020-0338)

[7. (Wang2015Overexpression) Wei Wang, Guang-Yao Li, Jian-Yu Zhu, Da-Bing Huang, Hang-Cheng Zhou, Wen Zhong, and Chu-Shu Ji. Overexpression of aggf1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma. Medical Oncology, March 2015. URL: http://dx.doi.org/10.1007/s12032-015-0574-2, doi:10.1007/s12032-015-0574-2. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12032-015-0574-2)

[8. (Fan2009Novel) Chun Fan, Ping Ouyang, Ayse A. Timur, Ping He, Sun-Ah You, Ying Hu, Tie Ke, David J. Driscoll, Qiuyun Chen, and Qing Kenneth Wang. Novel roles of gata1 in regulation of angiogenic factor aggf1 and endothelial cell function. Journal of Biological Chemistry, 284(35):23331–23343, August 2009. URL: http://dx.doi.org/10.1074/jbc.M109.036079, doi:10.1074/jbc.m109.036079. This article has 62 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M109.036079)